TPI bid for Baxter... Cash! TOX the next target? It's certainly going to get more attention as everyone asks who's next in the industry.
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%